97 related articles for article (PubMed ID: 12960829)
1. Impact of HIV infection on invasive cervical cancer in Kenyan women.
Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
[TBL] [Abstract][Full Text] [Related]
2. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL CANCER IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
4. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
[TBL] [Abstract][Full Text] [Related]
5. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
[TBL] [Abstract][Full Text] [Related]
6. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
9. HIV infection among Uganda women with cervical cancer: a retrospective study.
Sekirime WK; Gray R
Gynecol Obstet Invest; 2007; 63(4):222-8. PubMed ID: 17191009
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program.
Massad LS; Seaberg EC; Watts DH; Hessol NA; Melnick S; Bitterman P; Anastos K; Silver S; Levine AM; Minkoff H
AIDS; 2004 Jan; 18(1):109-13. PubMed ID: 15090836
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer in patients infected with the human immunodeficiency virus.
Leitao MM; White P; Cracchiolo B
Cancer; 2008 Jun; 112(12):2683-9. PubMed ID: 18438877
[TBL] [Abstract][Full Text] [Related]
12. Is HIV infection a risk factor for advanced cervical cancer?
Fruchter RG; Maiman M; Arrastia CD; Matthews R; Gates EJ; Holcomb K
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):241-5. PubMed ID: 9665501
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya.
Gichangi P; Estambale B; Bwayo J; Rogo K; Ojwang S; Njuguna E; Temmerman M
Int J Gynecol Cancer; 2006; 16(2):681-5. PubMed ID: 16681747
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus infection and invasive cervical carcinoma.
Maiman M; Fruchter RG; Guy L; Cuthill S; Levine P; Serur E
Cancer; 1993 Jan; 71(2):402-6. PubMed ID: 8093678
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive cervical cancer among women with, or at risk for, HIV infection.
Serraino D; Carrieri P; Pradier C; Bidoli E; Dorrucci M; Ghetti E; Schiesari A; Zucconi R; Pezzotti P; Dellamonica P; Franceschi S; Rezza G
Int J Cancer; 1999 Jul; 82(3):334-7. PubMed ID: 10399949
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
19. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain.
Mayans MV; Maguire A; Miret M; Casabona J
Sex Transm Dis; 1999 Oct; 26(9):500-3. PubMed ID: 10534202
[TBL] [Abstract][Full Text] [Related]
20. HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando Medical Centre.
Matovelo D; Magoma M; Rambau P; Massinde A; Masalu N
BMC Res Notes; 2012 Aug; 5():406. PubMed ID: 22862747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]